Related references
Note: Only part of the references are listed.The armed oncolytic adenovirus ZD55-IL-24 eradicates melanoma by turning the tumor cells from the self-state into the nonself-state besides direct killing
Hai-Jun Hu et al.
CELL DEATH & DISEASE (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue et al.
CANCER SCIENCE (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple- negative breast cancer to immune checkpoint therapy
Marie-Claude Bourgeois-Daigneault et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Adel Samson et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity
Prabhakaran Kumar et al.
JOURNAL OF AUTOIMMUNITY (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
Jennifer E. Kim et al.
CLINICAL CANCER RESEARCH (2017)
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy
E. Ilett et al.
GENE THERAPY (2017)
Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment
Jayson Hardcastle et al.
NEURO-ONCOLOGY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
Zuqiang Liu et al.
NATURE COMMUNICATIONS (2017)
Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
Liya Zhu et al.
THERANOSTICS (2017)
Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling
Julia V. Cockle et al.
NEURO-ONCOLOGY (2016)
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
Igor Puzanov et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
Karishma Rajani et al.
MOLECULAR THERAPY (2016)
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan et al.
NATURE MEDICINE (2016)
Immune-checkpoint blockade - durable cancer control
Elizabeth I. Buchbinder et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells
Sujing Yuan et al.
ONCOTARGET (2016)
Enhanced Anti-Tumor Efficacy through a Combination of Integrin alpha v beta 6-Targeted Photodynamic Therapy and Immune Checkpoint Inhibition
Liquan Gao et al.
THERANOSTICS (2016)
Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer
Zhiqiang Guo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Anti-PD-1 therapies- a new first-line option in advanced melanoma
Ryan J. Sullivan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
Targeting natural killer cells and natural killer T cells in cancer
Eric Vivier et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
Claus Garbe et al.
ONCOLOGIST (2011)
An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer
Suyang Zhong et al.
ACTA ONCOLOGICA (2010)
mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity
Rupesh Dash et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Detection of Mycoplasma in cell cultures
Lesley Young et al.
NATURE PROTOCOLS (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis
W. Qian et al.
LEUKEMIA (2008)
Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer
LL Zhao et al.
HUMAN GENE THERAPY (2005)
E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models
YH Wang et al.
NATURE BIOTECHNOLOGY (2003)
An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy
ZL Zhang et al.
CELL RESEARCH (2003)
Share Paper
